'Fours' company: Start-up Tetra thinks about new pathways in cognitio
By Randy Osborne
Wednesday, April 9, 2014
"It's not the usual model," explained Mark Gurney, CEO of Tetra Discovery Partners LLC, which is collaborating with the Broad Institute's Stanley Center for Psychiatric Research on drugs that might help cognitive impairment in schizophrenia.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.